Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke

Completed

Phase 2 Results N/A

Summary of Purpose

This study will allow determination of the pharmacokinetic and pharmacodynamics of SB424323 in a relevant population. The data from this study will be used along with other data to aid in choosing the most appropriate dose for the later phase study.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 13 January 2017.

1 Nov 2005 14 Oct 2005 1 Dec 2006 1 Dec 2006 1 Jan 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double-Blind
  • Purpose: Prevention
  • Endpoint: Pharmacokinetics/Dynamics Study
  • Intervention: Parallel Assignment

Contacts

Not available